According to a recent study by KPMG, approximately 93% of all U.S. multinational organizations are undergoing some level of transformation in their business models—ranging from adjusting business ...

Despite the many challenges that larger companies have in developing new products, to their credit, most medical device companies have mastered the process of Stage-gate portfolio management. Startups ...

Chao, Raul O., Kenneth C. Lichtendahl, and Yael Grushka-Cockayne. "Incentives in a Stage-Gate Process." Production and Operations Management 23, no. 8 (August 2014): 1286–1298.

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.